Awareness of Risk Reducing Strategies Amongst High Risk Women Referred for Breast Cancer Risk Assessment and Evaluation

被引：0
|
作者：
Alhassan, Basmah [1 ]
Rjeily, Marianne Bou [1 ]
Villareal-Corpuz, Victor [2 ]
Prakash, Ipshita [1 ,3 ,4 ,5 ]
Basik, Mark [1 ,6 ]
Boileau, Jean Francois [1 ]
Pollak, Michael [2 ,6 ]
Foulkes, William D. [1 ,2 ,7 ]
Wong, Stephanie M. [1 ,2 ]
机构：
[1] McGill Univ, Dept Surg, Med Sch, Montreal, PQ, Canada
[2] Jewish Gen Hosp Stroll Canc Prevent Ctr, Montreal, PQ, Canada
[3] McGill Univ, Dept Surg, Med Sch, Montreal, PQ, Canada
[4] Jewish Gen Hosp Segal Canc Ctr, Montreal, PQ, Canada
[5] Lady Davis Inst Med Res, Montreal, PQ, Canada
[6] McGill Univ, Dept Oncol, Med Sch, Montreal, PQ, Canada
[7] McGill Univ, Dept Human Genet, Med Sch, Montreal, PQ, Canada
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E53
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [31] Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent
    Evans, D. Gareth R.
    Lalloo, Fiona
    Ashcroft, Linda
    Shenton, Andrew
    Clancy, Tara
    Baildam, Andrew D.
    Brain, Anne
    Hopwood, Penelope
    Howell, Anthony
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) : 2318 - 2324
  • [32] Breast Cancer Risk Assessment and Screening in Average-Risk Women
    Pearlman, Mark
    Jeudy, Myrlene
    Chelmow, David
    OBSTETRICS AND GYNECOLOGY, 2017, 130 (01): : E1 - E16
  • [33] Evaluation of breast screening strategies in a high risk breast and ovarian cancer clinic
    Knisely, Anne T.
    Stewart, Martha E.
    Garcia, Christine
    Thomas, Martha H.
    Modesitt, Susan C.
    Ring, Kari L.
    GYNECOLOGIC ONCOLOGY REPORTS, 2020, 33
  • [34] Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review
    Meiser, B.
    Wong, W. K. T.
    Peate, M.
    Julian-Reynier, C.
    Kirk, J.
    Mitchell, G.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2017, 15
  • [35] Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review
    B. Meiser
    W. K. T. Wong
    M. Peate
    C. Julian-Reynier
    J. Kirk
    G. Mitchell
    Hereditary Cancer in Clinical Practice, 15
  • [36] Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer
    Vogel, Victor G.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (04): : 782 - 789
  • [37] STRATEGIES FOR REDUCING CARDIOVASCULAR RISK IN WOMEN
    BURKMAN, RT
    JOURNAL OF REPRODUCTIVE MEDICINE, 1991, 36 (03) : 238 - 246
  • [38] Reducing breast cancer risk
    Stephenson, Joan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (11): : 1182 - 1182
  • [39] The evaluation of women with familial risk of breast cancer
    Boetes, C
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (03) : 97 - 101
  • [40] Reducing the risk of breast cancer
    Pederson, Holly J.
    Al-Hilli, Zahraa
    Kurian, Allison W.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2022, 89 (11) : 643 - 652
12345